Cargando…
Brain-Derived Neurotropic Factor, Vascular Endothelial Growth Factor and Matrix Metalloproteinases as Markers of Metabolic Status in Non-Growth Hormone-Treated Girls With Turner Syndrome
BACKGROUND: Turner syndrome (TS) presents a high risk of congenital heart defects and may predispose to both obesity and related metabolic complications. Hence the search for new markers as potential early predictors of the metabolic syndrome (MetS) and cardiovascular diseases appears warranted. OBJ...
Autores principales: | Błaszczyk, Ewa, Gawlik, Jakub, Gieburowska, Joanna, Tokarska, Agnieszka, Kimsa-Furdzik, Małgorzata, Hibner, Grzegorz, Francuz, Tomasz, Gawlik, Aneta Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429805/ https://www.ncbi.nlm.nih.gov/pubmed/34512552 http://dx.doi.org/10.3389/fendo.2021.722199 |
Ejemplares similares
-
Effect of Growth Hormone Treatment on the Concentration of Selected Metabolic Markers in Girls With Turner Syndrome
por: Błaszczyk, Ewa, et al.
Publicado: (2022) -
Selected Metabolic Markers in Girls with Turner Syndrome: A Pilot Study
por: Błaszczyk, E., et al.
Publicado: (2018) -
Components of the metabolic syndrome in girls with Turner syndrome treated with growth hormone in a long term prospective study
por: Błaszczyk, Ewa, et al.
Publicado: (2023) -
Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer
por: Hibner, Grzegorz, et al.
Publicado: (2018) -
Autoimmunity Predisposition in Girls With Turner Syndrome
por: Wegiel, Malgorzata, et al.
Publicado: (2019)